Determinants of chronic otitis media with effusion in preschool children: a case–control study

por Walker, Rebecca E., Bartley, Jim, Flint, David, Thompson, John M. D., Mitchell, Edwin A.
Publicado 2017

Drug screening of biopsy-derived spheroids using a self-generated microfluidic concentration gradient

por Mulholland, Theresa, McAllister, Milly, Patek, Samantha, Flint, David, Underwood, Mark, Sim, Alexander, Edwards, Joanne, Zagnoni, Michele
Publicado 2018

Brain Radiation Necrosis Outside the Target Volume After Proton Radiation Therapy: Analyses of Multiparametric Imaging and Proton Biologic Effectiveness

por Bronk, Julianna K., Amer, Ahmad, Khose, Swapnil, Flint, David, Adair, Antony, Yepes, Pablo, Grosshans, David, Johnson, Jason, Chung, Caroline
Publicado 2022

Nasal microbial composition and chronic otitis media with effusion: A case-control study

por Walker, Rebecca E., Walker, Caroline G., Camargo, Carlos A., Bartley, Jim, Flint, David, Thompson, John M. D., Mitchell, Edwin A.
Publicado 2019

Gold Nanoparticles for the Improved Anticancer Drug Delivery of the Active Component of Oxaliplatin

por Brown, Sarah D., Nativo, Paola, Smith, Jo-Ann, Stirling, David, Edwards, Paul R., Venugopal, Balaji, Flint, David J., Plumb, Jane A., Graham, Duncan, Wheate, Nial J.
Publicado 2010

Loss of IGFBP2 mediates alveolar type 2 cell senescence and promotes lung fibrosis

por Chin, Chiahsuan, Ravichandran, Ranjithkumar, Sanborn, Kristina, Fleming, Timothy, Wheatcroft, Stephen B., Kearney, Mark T., Tokman, Sofya, Walia, Rajat, Smith, Michael A., Flint, David J., Mohanakumar, Thalachallour, Bremner, Ross M., Sureshbabu, Angara
Publicado 2023

An empirical model of proton RBE based on the linear correlation between x‐ray and proton radiosensitivity

por Flint, David B., Ruff, Chase E., Bright, Scott J., Yepes, Pablo, Wang, Qianxia, Manandhar, Mandira, Kacem, Mariam Ben, Turner, Broderick X., Martinus, David K. J., Shaitelman, Simona F., Sawakuchi, Gabriel O.
Publicado 2022

Translational pharmacology of an inhaled small molecule αvβ6 integrin inhibitor for idiopathic pulmonary fibrosis

por John, Alison E., Graves, Rebecca H., Pun, K. Tao, Vitulli, Giovanni, Forty, Ellen J., Mercer, Paul F., Morrell, Josie L., Barrett, John W., Rogers, Rebecca F., Hafeji, Maryam, Bibby, Lloyd I., Gower, Elaine, Morrison, Valerie S., Man, Yim, Roper, James A., Luckett, Jeni C., Borthwick, Lee A., Barksby, Ben S., Burgoyne, Rachel A., Barnes, Rory, Le, Joelle, Flint, David J., Pyne, Susan, Habgood, Anthony, Organ, Louise A., Joseph, Chitra, Edwards-Pritchard, Rochelle C., Maher, Toby M., Fisher, Andrew J., Gudmann, Natasja Stæhr, Leeming, Diana J., Chambers, Rachel C., Lukey, Pauline T., Marshall, Richard P., Macdonald, Simon J. F., Jenkins, R. Gisli, Slack, Robert J.
Publicado 2020